Outcomes after anti-rheumatic drug use before and during pregnancy: a cohort study among 150 000 pregnant women and expectant fathers

Anti-TNF therapies and pregnancy: outcome of 130 pregnancies in the British Society for Rheumatology Biologics Register

(2011) S. M. M. Verstappen et al.   ANNALS OF THE RHEUMATIC DISEASES

A safety assessment of tumor necrosis factor antagonists during pregnancy

(2010) Vanessa C Osting et al.   Expert Opinion On Drug Safety

Rheumatoid arthritis and pregnancy: where do we go from here?

(2010) E. F. Chakravarty   JOURNAL OF INTERNAL MEDICINE

The management of rheumatic diseases in pregnancy

(2010) K Mitchell et al.   SCANDINAVIAN JOURNAL OF RHEUMATOLOGY

A Safety Assessment of Tumor Necrosis Factor Antagonists During Pregnancy: A Review of the Food and Drug Administration Database

(2009) J. D. CARTER et al.   JOURNAL OF RHEUMATOLOGY

Can Tumor Necrosis Factor Inhibitors Be Safely Used in Pregnancy?

(2009) Y. M. ALI et al.   JOURNAL OF RHEUMATOLOGY

Management of RA medications in pregnant patients

(2009) Monika Østensen et al.   Nature Reviews Rheumatology

Use of antirheumatic drugs in mothers and fathers before and during pregnancy-a population-based cohort study

(2009) Kirsten K Viktil et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Prescription drug use among fathers and mothers before and during pregnancy. A population-based cohort study of 106 000 pregnancies in Norway 2004–2006

(2008) Anders Engeland et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY